Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
- Status
- RECRUITING
- Phase
- PHASE1
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence
- Status
- COMPLETED
- Phase
- N/A
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combined HCC-MFCCC
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
- Status
- COMPLETED
- Phase
- NA
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE1
Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)
- Status
- WITHDRAWN
- Phase
- NA
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib
- Status
- COMPLETED
- Phase
- PHASE2
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
Chronic Hepatitis B Virus Infection in Zambia
- Status
- COMPLETED
- Phase
- N/A
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.
- Status
- COMPLETED
- Phase
- NA
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
- Status
- UNKNOWN
- Phase
- PHASE2
Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA